Skip to search formSkip to main contentSkip to account menu

quinbolone

Known as: 17 beta-(1-cyclopenten-1-yloxy)androsta-1,4- dien-3-one 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Androstadienes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Le dopage : enjeux sanitaires et financiers, produits dopants et rôle du pharmacien
Le dopage ne doit pas etre apprehende seulement en reference aux sportifs de haut niveau. Il ne doit non plus etre insere dans un… 
1980
1980
[Quinbolone in the therapy of anemia in uremic patients during periodic hemodialytic treatment].
1977
1977
[Pituitary activity and quinbolone].
1972
1972
[Controlled studies of the comparative effects of an anabolic steroid (quinbolone) and cobamamide on weight gain, skinfold thickness and secondary sex characters in a group of children of both sexes…
1972
1972
[Human pharmacological study of quinbolone. Clinical and laboratory investigations of the effects of anabolic treatment in aged women].
1971
1971
Metabolism of 1-dehydroandrostanes in man. I. Metabolism of 17 -hydroxyandrosta-1,4-dien-3-one, 17 -cyclopent-1'-enyloxyandrosta-1,4-dien-3-one (quinbolone) and androsta-1,4-diene-3,17-dione (1).
1971
1971
[Pituitary function during treatment with quinbolone].
1967
1967
[Evaluation of a new anabolic steroid, MK 810 (Quinbolone)].
1967
1967
[The action of quinbolone on nitrogen metabolism in humans].
1965
1965
[Considerations on the use of a new non 17-alpha-alkylated anabolic steroid, active orally: quinbolone. Study of liver function].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)